These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25446301)

  • 1. Role of delta-aminolevulinic acid in the symptoms of acute porphyria.
    Bissell DM; Lai JC; Meister RK; Blanc PD
    Am J Med; 2015 Mar; 128(3):313-7. PubMed ID: 25446301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Wang B; Bonkovsky HL; Lim JK; Balwani M
    Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
    Sardh E; Rejkjaer L; Andersson DE; Harper P
    Clin Pharmacokinet; 2007; 46(4):335-49. PubMed ID: 17375984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
    Bonkovsky HL; Dixon N; Rudnick S
    Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovisceral porphyrias: what a hematologist needs to know.
    Bonkovsky HL
    Hematology Am Soc Hematol Educ Program; 2005; ():24-30. PubMed ID: 16304355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
    Balwani M; Sardh E; Ventura P; Peiró PA; Rees DC; Stölzel U; Bissell DM; Bonkovsky HL; Windyga J; Anderson KE; Parker C; Silver SM; Keel SB; Wang JD; Stein PE; Harper P; Vassiliou D; Wang B; Phillips J; Ivanova A; Langendonk JG; Kauppinen R; Minder E; Horie Y; Penz C; Chen J; Liu S; Ko JJ; Sweetser MT; Garg P; Vaishnaw A; Kim JB; Simon AR; Gouya L;
    N Engl J Med; 2020 Jun; 382(24):2289-2301. PubMed ID: 32521132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New type of acute porphyria with porphobilinogen synthase (delta-aminolevulinic acid dehydratase) defect in the homozygous state.
    Doss M; Schneider J; Von Tiepermann R; Brandt A
    Clin Biochem; 1982 Feb; 15(1):52-5. PubMed ID: 7067077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case 38-2021: A 76-Year-Old Woman with Abdominal Pain, Weight Loss, and Memory Impairment.
    Willett LL; Bromberg GK; Chung R; Leaf RK; Goldman RH; Dickey AK
    N Engl J Med; 2021 Dec; 385(25):2378-2388. PubMed ID: 34910867
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Aminolevulinate dehydratase porphyria: Update on hepatic 5-aminolevulinic acid synthase induction and long-term response to hemin.
    Lahiji AP; Anderson KE; Chan A; Simon A; Desnick RJ; Ramanujam VMS
    Mol Genet Metab; 2020 Dec; 131(4):418-423. PubMed ID: 33199206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family with acute intermittent porphyria.
    Billoo AG; Lone SW
    J Coll Physicians Surg Pak; 2008 May; 18(5):316-8. PubMed ID: 18541093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute intermittent porphyria.
    Herrick AL; McColl KE
    Best Pract Res Clin Gastroenterol; 2005 Apr; 19(2):235-49. PubMed ID: 15833690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.
    Bonkovsky HL; Maddukuri VC; Yazici C; Anderson KE; Bissell DM; Bloomer JR; Phillips JD; Naik H; Peter I; Baillargeon G; Bossi K; Gandolfo L; Light C; Bishop D; Desnick RJ
    Am J Med; 2014 Dec; 127(12):1233-41. PubMed ID: 25016127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute attacks of hepatic porphyria. Treatment with hematin. 5 cases].
    Devars du Mayne JF; Deybach JC; Phung L; Likforman J; Tenhunen R; Cerf M; Nordmann Y
    Presse Med; 1986 Oct; 15(33):1673-6. PubMed ID: 2947113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning.
    Hermes-Lima M; Valle VG; Vercesi AE; Bechara EJ
    Biochim Biophys Acta; 1991 Jan; 1056(1):57-63. PubMed ID: 1984785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrologists and porphyrias].
    Canavese C; Gabrielli D; Guida C; Cappellini MD
    G Ital Nefrol; 2002; 19(4):393-412. PubMed ID: 12369042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
    Lindberg RL; Porcher C; Grandchamp B; Ledermann B; Bürki K; Brandner S; Aguzzi A; Meyer UA
    Nat Genet; 1996 Feb; 12(2):195-9. PubMed ID: 8563760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Porphyria. What to think in the absence of a cause of abdominal pain].
    Bouizegarene P; Puy H; da Silva VP; Deybach JC
    Rev Prat; 2010 Dec; 60(10):1341-4. PubMed ID: 21425523
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid.
    Bechara EJ
    Braz J Med Biol Res; 1996 Jul; 29(7):841-51. PubMed ID: 9070373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perplexing acute or chronic somatic or psychiatric symptoms: possibly due to porphyria].
    Schattenberg AV; de Pauw BE
    Ned Tijdschr Geneeskd; 1998 Aug; 142(32):1801-4. PubMed ID: 9856148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematin treatment of acute intermittent porphyria. A case report (author's transl)].
    Marchiori PE; de Assis JL; Scaff M; Do Serro-Azul LG; Moraes EC; Bacheschi LA; Yassuda N
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):325-33. PubMed ID: 531276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.